Organon pays up to $1 . 2B to acquire Dermavant and its steroid – free skin cream Vtama
This deal will see Organon acquire Roivant's dermatology business, including its pipeline of promising drug candidates, and its established manufacturing facilities. The acquisition is a strategic move for Organon, aiming…
